The content on this site is intended for healthcare professionals only
HARMONY - a bench to bedside process
The importance of the HARMONY project in Europe
Different perspectives shaping the HARMONY project
Returns from data sharing in HARMONY
The Sanger Institute and personalised genomics
Worrying results from genotyping quality assessments
Focus on screening, not biomarkers
Inequalities in immuno-oncology access across Europe
Measuring innovation and value in healthcare systems
Could personalised medicine increase inequality to medicine access?
The economics of personalised medicine in low and middle income countries
Creating a culture of shared data
